Recipient body size and cadaveric renal allograft survival

Journal of the American Society of Nephrology

Volumn 7, Issue 1, 1996, Pages 151-157

  Feldman, Harold I ^a   Fazio, Ignazio ^c   Roth, David ^b   Berlin, Jesse A ^a   Brayman, Kenneth ^a   Burns, J Eileen ^a   Grossman, Robert A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

Author keywords

Body mass index; Body surface area; Kidney transplantation; Metabolic rate; Survival analysis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BODY SIZE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PRIORITY JOURNAL;

EID: 0030040746     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v71151     Document Type: Article

References (41)

1. Brenner BM, Milford EL: Nephron underdosing: A programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993;21(Suppl 2):66-72.
2. Fotino S: The solitary kidney: A model of chronic hyperfiltration in humans. Am J Kidney Dis 1989;13:88-98.
3. Heemann UW, Azuma H, Tullius SG, Mackenzie H, Brenner BM, Tilney NL: The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Transplantation 1994;58:1317-1322.
4. Mackenzie HS, Azuma H, Troy JL, Tilney NL, Brenner BM: In experimental transplantation, two kidneys are better than one. Abstracts of the American Society of Nephrology 27th Annual Meeting, Chicago, IL, 1994:173.
5. Mackenzie HS, Tullius SG, Heemann UW, et al.: Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 1994;94: 2148-2152.
6. Dumler F, Rocher LL, Greenberg LA, Chang CH, Neill JS: Impact of glomerular mass on the development of renal allograft glomerulopathy. American Society of Transplant Physicians Abstract P-189, 14th Annual Meeting, 1995:173.
7. Cecka JM: Donor and preservation factors. In: Terasaki PI, Ed. Clinical Transplants 1988. Los Angeles: UCLA Tissue Typing Laboratory; 1988:399.
8. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-659.
9. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981;241:F85-F93.
10. Watnick TJ, Jenkins RR, Rackoff P, Baumgarten A, Bia MJ: Microalbuminuria and hypertension in long-term renal donors. Transplantation 1988;45:59-65.
11. Miller IJ, Suthanthiran M, Riggio RR, et al.: Impact of renal donation: Long-term clinical and biochemical follow-up of living donors in a single center. Am J Med 1985;79:201-208.
12. Hakim RH, Goldszer RC, Brenner RM: Hypertension and proteinuria: Long-term sequelae of uninephrectomy in humans. Kidney Int 1984;25:930-936.
13. Vincenti F, Amend WJC Jr, Kaysen G, et al.: Long-term renal function in kidney donors: Sustained compensatory hyperfiltration with no adverse effects. Transplantation 1983;36:626-629.
14. Andersen CF, Velosa JA, Frohnert PP, et al.: The risks of unilateral nephrectomy: Status of kidney donors 10 to 20 years postoperatively. Mayo Clin Proc 1985;60:367-374.
15. Williams SL, Oler J, Jorkasky DK: Long-term renal function in kidney donors: A comparison of donors and their siblings. Ann Intern Med 1986;105:1-8.
16. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR: Long-term follow-up after partial removal of solitary kidney. N Engl J Med 1991;325:1058-1062.
17. Holley JL, Shapiro R, Lopatin WB, Tzakis AG, Hakala TR, Starzl TE: Obesity as a risk factor following cadaveric renal transplantation. Transplantation 1990;49: 387-389.
18. Blumke M, Keller E, Eble F, Nausner M, Kirste G: Obesity in kidney transplant patients as a risk factor. Transplant Proc 193;25:2618.
19. Gill IS, Hodge EE, Novick AC, Steinmuller DR, Garred D: Impact of obesity on renal transplantation. Transplant Proc 1993;25:1047-1048.
20. Pirsch JD, Armbrust MJ, Knechtle SJ, et al.: Obesity as a risk factor following renal transplantation. Transplantation 1995;59:631-647.
21. DuBois D, DuBois EF: Clin Cal. Arch Intern Med 1916; 17:863.
22. Mifflin MD, St. Joer ST, Hill LA, Scott BJ, Daugherty SA, Koh YO: A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990;51:1241-1247.
23. Harris JA, Benedict FG: A Biometric Study of Basal Metabolism in Man. Carnegie Institute of Washington, Publication No. 279. Washington, DC, 1919.
24. Klieber M: Body size and metabolism. Hilgardia 1932;6: 315-352.
25. Griffiths GJ, Cartwright G, McLachlan MSF: Estimation of renal size from radiographs: Is the effort worthwhile? Clin Radiol 1974;26:249-256.
26. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc 1972;135[Series A]:185-207.
27. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
28. Cox DB: Regression models and life tables. J R Stat Soc 1972:34[Series B]:187-220.
29. Lee ET: Statistical Models for Survival Data Analysis. Belmont, CA: Lifetime Learning Publications; 1980.
30. Breslow NE, Day NE: Statistical Methods in Cancer Research: Volume 1, The Analysis of Case-Control Studies. Lyon: World Health Organization, International Agency for Research on Cancer; 1980.
31. Mickey RM, Greenland S: The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;129:125-137.
32. Davies DF, Shock NW: Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excreting capacity in adult males. J Clin Invest 1950;29:496-507.
33. Harmon WE, Jabs K: Special issues in pediatric renal transplantation. Semin Nephrol 1992;12:353-363.
34. Merion RM, Twork AM, Rosenberg L, et al.: Obesity and renal transplantation. Surg Gynecol Obstet 1991;172: 367-376.
35. Kiprov DD, Colvin RB, McCluskey, RT: Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest 1982;46:275-281.
36. Rugiu C, Oldrizzi L, Lupo A, et al.: Clinical features of patients with solitary kidneys. Nephron 1986;43:10-15.
37. Terasaki PI, Cecka JM, Takemoto S, et al.: Overview. In: Terasaki P, Ed. Clinical Transplants 1988. Los Angeles: UCLA Tissue Typing Laboratory; 1988:428-430.
38. Kaplan C, Pasternack B, Shah H, Gallo G: Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975;80:227-234.
39. Kappel B, Olsen S: Cortical interstitial tissue in the normal kidney and sclerosed glomeruli tissue related to age and sex. A quantitative study. Virchows Archiv 1980;387:271-277.
40. Gaston RS, Hudson SL, Julian BA, et al.: Impact of donor/recipient size matching in renal transplantation at a single center. American Society of Transplant Physicians Abstract 161, 14th Annual Meeting, 1995:114.
41. Flechner SM, Kolbeinsson ME, Tam J, Lum B: The impact of body weight on cyclosporine pharmacokinetics in renal transplant recipients. Transplantation 1989;47: 806-10.